For most of our lives, we are taught a fairly simple story about aging.
We get older.
Our hair turns gray.
Our joints become stiffer.
Our skin changes.
Our muscles weaken.
Eventually, the machinery of the body begins to wear down.
But modern biology is discovering that aging is much more complicated than simply “wear and tear.”
Some of the most interesting research is happening at a level we cannot see.
Inside our cells.
And scientists are asking a strange but important question:
Why do some old cells refuse to die?
The answer may help explain why inflammation increases with age, why tissues lose some of their ability to function, and perhaps even why certain age related diseases become more common.
These cells are called senescent cells.
You may have heard another name for them:
Zombie cells.
That nickname sounds like something created for a horror movie, but there is actually a good reason for it.
Senescent cells are not quite functioning normally.
They have stopped dividing.
Yet they have not disappeared.
They remain in our tissues, sometimes releasing chemical signals that can affect the cells around them.
Researchers increasingly believe that the accumulation of these cells is one of the important biological features of aging.
Cells Are Supposed to Have an Exit Plan
Cell death sounds like a bad thing.
But controlled cell death is essential to keeping us alive.
The body is constantly replacing cells.
Old cells die.
Damaged cells are removed.
New cells take their place.
One important process is called apoptosis, often described as programmed cell death.
You might think of it as a cellular retirement program.
When a cell becomes damaged beyond repair, the body can send signals telling that cell to dismantle itself.
The remains are then cleared away.
This is one of the body’s housekeeping systems.
Senescent cells behave differently.
They stop dividing, but they often develop resistance to the normal signals that would otherwise cause them to die.
So now we have a cell that is no longer working normally…
but is still hanging around.
That is where the trouble can begin.
Why Would Nature Create Such a Cell?
Because cellular senescence is not inherently bad.
In fact, it may have evolved partly to protect us.
Imagine that one of your cells suffers serious DNA damage.
You do not necessarily want that damaged cell continuing to reproduce.
Every time a cell divides, it copies its genetic material.
If seriously damaged cells keep dividing, some may eventually become cancerous.
Senescence can put on the brakes.
The cell essentially receives an instruction:
Stop dividing.
That can be beneficial.
Cellular senescence plays a role in tumor suppression, tissue remodeling, development and wound healing.
So once again, biology refuses to give us a simple good guy and bad guy story.
A senescent cell can be helpful.
The problem seems to arise when too many of these cells remain for too long.
The Guest Who Never Leaves
Imagine inviting someone to stay in your house for a weekend.
They help you fix something.
Wonderful.
But six months later they are still sitting on the sofa.
Now you have a different situation.
That is one way to think about senescent cells.
Temporary senescence can be useful.
Persistent senescence can become harmful.
When we are younger, the immune system can recognize and remove many senescent cells.
But research suggests that this cleanup becomes less efficient with age.
A major 2026 review in Nature Reviews Immunology describes how immune surveillance is important for removing senescent cells and maintaining healthy tissues. When that surveillance becomes less effective, including during aging, senescent cells can accumulate.
Now something interesting begins to happen.
These cells do not necessarily sit quietly.
Old Cells Can Become Noisy Neighbors
Many senescent cells release a mixture of inflammatory molecules and other signals.
Scientists call this the:
Senescence Associated Secretory Phenotype.
Fortunately, they shortened that to:
SASP.
Think of SASP as a chemical broadcast.
A senescent cell may release inflammatory substances, growth factors, enzymes and signaling molecules into the surrounding tissue.
Those signals can influence nearby cells.
In some situations, this communication is useful.
In others, persistent SASP activity may contribute to chronic inflammation and tissue dysfunction.
And this is where aging research becomes particularly interesting.
Aging is associated with a low level chronic inflammatory state sometimes called inflammaging.
Scientists are studying whether accumulating senescent cells may be one contributor to that inflammatory environment.
Not the only contributor.
But potentially an important one.
Why Don’t These Cells Just Die?
That question brings us back to the mystery.
Senescent cells can activate survival mechanisms that help them resist apoptosis.
In other words, a damaged old cell can become surprisingly good at staying alive.
Different types of senescent cells may use different survival pathways, which is one reason eliminating them selectively is so difficult.
This is important because scientists do not want to simply kill cells indiscriminately.
The goal would be to remove harmful senescent cells while leaving normal healthy cells alone.
That is much harder than it sounds.
Senescent cells also differ depending on which tissue they are found in, what caused the senescence, and how long they have been present.
There may not be one universal “zombie cell switch.”
What Does This Have to Do With Aging?
Potentially quite a lot.
Researchers have connected senescent cell accumulation with many conditions associated with aging.
These include areas of investigation involving cardiovascular disease, metabolic dysfunction, neurological disease, fibrosis and physical decline.
That does not mean senescent cells are the single cause of these diseases.
Aging is much too complicated for that.
But cellular senescence is now considered one of the major biological processes involved in aging.
And once scientists identified the problem, the next question was inevitable.
What happens if we get rid of these cells?
Enter the Senolytics
A new class of experimental treatments is being studied called senolytics.
The idea is straightforward.
Find drugs or other therapies that selectively kill harmful senescent cells.
Leave healthy cells alone.
In animal studies, this concept has produced some very interesting results.
Research in preclinical models has shown improvements in various measures of tissue function and healthspan after senescent cells were removed or reduced.
That helped launch an entire field of research sometimes called senotherapy.
But this is where we need to slow down.
Because mouse research is not the same thing as proven human medicine.
The Internet Is Moving Faster Than the Science
Search online and you will find products claiming to eliminate zombie cells.
You will find supplements marketed as senolytics.
You will find anti aging protocols.
You may even find clinics suggesting that they can already manipulate cellular aging.
This is where healthy skepticism becomes useful.
Human research is underway.
But scientists are still working through very basic questions.
Which senescent cells should we eliminate?
Which ones should we leave alone?
How do we identify them?
How often would treatment be needed?
What are the side effects?
Could removing beneficial senescent cells interfere with wound healing or other protective functions?
Researchers are also still trying to develop reliable biomarkers that tell us how many senescent cells are present and whether a therapy is actually reducing them.
That is a long way from saying:
“Take this pill and reverse aging.”
We are not there.
Dasatinib and Quercetin
One of the combinations frequently discussed in senolytic research is dasatinib plus quercetin.
Dasatinib is a prescription cancer medication.
Quercetin is a plant compound found in various foods and supplements.
The combination has shown senolytic activity in laboratory and preclinical research, and it has been investigated in early human studies.
But that does not mean people should start experimenting with it themselves.
Dasatinib is a powerful prescription drug with potentially significant adverse effects.
The scientific question is whether carefully controlled senolytic therapies may eventually have medical uses.
That is very different from turning preliminary research into a do it yourself longevity program.
Maybe We Don’t Have to Kill the Cells
Scientists are studying another approach as well.
Instead of removing senescent cells entirely, perhaps we can quiet them down.
These treatments are often called senomorphics.
A senolytic says:
Remove the troublesome cell.
A senomorphic says:
Change the way the troublesome cell behaves.
Remember the SASP inflammatory signals?
Senomorphic approaches aim to reduce some of those harmful secretions without necessarily killing the cell.
Both strategies remain active areas of research.
Which will ultimately prove more useful?
We do not know.
There may not even be one answer.
Different diseases and tissues could require entirely different approaches.
Scientists Are Also Looking at the Immune System
Another fascinating direction is to help the immune system recognize senescent cells more effectively.
Researchers are investigating approaches involving antibodies, vaccines and even engineered immune cells designed to recognize markers on senescent cells.
This resembles strategies already being developed in cancer treatment.
Instead of giving a drug that poisons a target cell, you teach or assist the immune system to identify the target.
The 2025 review literature describes immune based strategies, including CAR T cell approaches and senolytic vaccines, as emerging possibilities in this field.
These approaches remain experimental.
But they show how quickly the science of aging is changing.
Aging May Become Something We Can Measure More Precisely
For most of history, we measured aging with a calendar.
How old are you?
But two people who are both 75 may be biologically very different.
One may be hiking.
Another may be struggling to walk across the room.
Chronological age tells us how long someone has been alive.
It does not necessarily tell us how well the body is functioning.
Researchers are now investigating biological markers of aging.
Cellular senescence may eventually become part of that picture.
Imagine if doctors could someday measure certain aging processes the same way they measure cholesterol or blood pressure.
That possibility is still developing.
But it represents a very different way of thinking about aging.
This Is What Elderhood Is Really About
The point of longevity research is not simply to add years.
Living longer without preserving function is not the goal.
The real prize is healthspan.
The years during which we can still participate in life.
Walk.
Think.
Travel.
Learn.
Maintain relationships.
Make our own decisions.
Remain curious.
Remain useful.
Remain connected with the world.
If scientists eventually learn how to reduce some of the biological damage associated with aging, the most important result may not be that people live to 110.
It may be that an 80 year old functions more like today’s 70 year old.
Or that disability begins later.
Or that recovery from illness improves.
That is where this science becomes deeply relevant to Elderhood.
What Can We Do Today?
There is no approved treatment that allows healthy people to simply eliminate senescent cells and become younger.
Anyone telling you otherwise is moving well ahead of the evidence.
But the absence of a magic treatment does not mean we are powerless.
Exercise, sleep, nutrition, avoiding tobacco, maintaining healthy blood pressure and staying socially and mentally engaged remain among the most practical ways we know to protect health as we age.
Some research also suggests that lifestyle factors, including physical activity, may influence biological pathways associated with cellular senescence, although scientists are still studying exactly how those relationships work.
In other words, while the laboratory works on tomorrow’s medicine…
we still have today’s tools.
Use them.
The Most Interesting Question May Not Be How Long We Live
For centuries we treated aging as something that simply happened to us.
Now scientists are breaking the process apart.
Cell by cell.
Protein by protein.
Signal by signal.
Why do cells become senescent?
Why do they accumulate?
Why does the immune system stop removing them efficiently?
Which cells cause harm?
Which cells help us?
Can we eliminate the harmful ones?
Can we quiet their inflammatory signals?
Can we improve the body’s ability to clean them up?
Nobody knows where this research will ultimately lead.
That is precisely what makes it so interesting.
Because the question is beginning to change.
Instead of asking only:
Why do we get old?
Scientists are increasingly asking:
Which parts of aging can we influence?
That is a very different question.
And it may produce some very different answers.
We have entered the Age of Longevity.
The goal is not to pretend aging does not exist.
The goal is to understand it.
Adapt to it.
Preserve function.
Stay engaged.
And remain open to what science may teach us next.
Because even after thousands of years of studying ourselves…
the human body is still giving up its secrets.